GlassScriptPhysician profile
Blaine S Kristo
NPI 1124128822
$4,329.25
in general payments reported to CMS, 2019-2025
43 companies · $507 in 2025
The $507 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $661 · 2020: $272 · 2021: $450 · 2022: $1,020 · 2023: $1,250 · 2024: $169 · 2025: $507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,726 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,726.45 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $611.39 | 2019-2025 | Xtandi, Myrbetriq |
| Dornier Medtech America, INC | $454.03 | 2023 | Dornier Medtech |
| Ethicon US, LLC | $402.13 | 2019-2023 | Vistaseal, Echelon; Endopath, Mega Soft |
| Urovant Sciences INC | $285.50 | 2021-2022 | |
| Boston Scientific Corporation | $201.39 | 2019-2025 | Lumenis Pulse 120h, Lynx System, Lithovue |
| Olympus America INC. | $198.07 | 2019-2024 | Itind System |
| Janssen Biotech, INC. | $174.05 | 2019-2022 | |
| Tolmar Pharmaceuticals, INC. | $172.69 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $162.59 | 2023-2025 | Orgovyx, Gemtesa |
| Teleflex LLC | $153.35 | 2022-2025 | Urolift, Barrigel |
| Coloplast Corp | $140.47 | 2019-2025 | |
| Procept Biorobotics Corporation | $125.79 | 2022-2025 | |
| Endo Pharmaceuticals INC. | $122.15 | 2019-2020 | |
| Abbvie INC. | $118.57 | 2020-2024 | |
| Merck Sharp & Dohme LLC | $111.80 | 2020-2023 | Lynparza, Keytruda |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blaine Kristo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.